X0306 4 2021-11-05 0000816956 CONMED Corp CNMD 0001242753 TRYNISKI MARK E 1964 PENFOLD WAY BALDWINSVILLE NY 13027 1 Common Stock 2021-11-05 4 M 0 4892 51.90 A 13188 D Common Stock 2021-11-05 4 S 0 4792 156.508 D 8396 D Common Stock 2021-11-05 4 S 0 100 157.11 D 8296 D Common Stock 2021-11-05 4 M 0 3399 69.03 A 11695 D Common Stock 2021-11-05 4 S 0 2899 156.439 D 8796 D Common Stock 2021-11-05 4 S 0 500 157.061 D 8296 D Common Stock 2021-11-05 4 M 0 2886 79.94 A 11182 D Common Stock 2021-11-05 4 S 0 2386 156.436 D 8796 D Common Stock 2021-11-05 4 S 0 500 156.949 D 8296 D Common Stock 2021-11-05 4 M 0 1843 73.94 A 10139 D Common Stock 2021-11-05 4 S 0 1743 156.483 D 8396 D Common Stock 2021-11-05 4 S 0 100 157.05 D 8296 D Options To Purchase Common Stock 51.90 2021-11-05 4 M 0 4892 0 D 2018-06-01 2027-06-01 Common Stock 4892 0 D Options To Purchase Common Stock 69.03 2021-11-05 4 M 0 3399 0 D 2019-06-01 2028-06-01 Common Stock 3399 0 D Options To Purchase Common Stock 79.94 2021-11-05 4 M 0 2886 0 D 2020-06-01 2029-06-03 Common Stock 2886 0 D Options To Purchase Common Stock 73.94 2021-11-05 4 M 0 1843 0 D 2021-06-01 2030-06-01 Common Stock 1843 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.01 to $156.96. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.82 to $156.81. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.83 to $157.37. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.81 to $156.76. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.86 to $157.12. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.01 to $156.96. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Sarah M Oliker for Mark E. Tryniski by Power of Attorney 2021-11-08